Trials / Completed
CompletedNCT05056155
Systane Complete Multi-symptom Relief
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate effective symptom relief with the use of Systane Complete among subjects with dry eye disease (DED).
Detailed description
Subjects will be expected to attend a screening/baseline visit and one additional visit at Day 28 (± 2 days), with a telephone call visit conducted at Day 14 (± 2 days). Individual duration of subject participation will be approximately 28 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Systane Complete | Propylene glycol 0.6% eye drops for replenishing deficiencies in both the lipid and aqueous layers of the tear film |
Timeline
- Start date
- 2021-11-09
- Primary completion
- 2022-03-25
- Completion
- 2022-03-25
- First posted
- 2021-09-24
- Last updated
- 2022-03-29
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05056155. Inclusion in this directory is not an endorsement.